Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.

A two phase radioimmunotherapy based on bispecific MAbs in which one arm recognises a tumour antigen and the other a radiolabelled chelate, may prove more effective in the treatment of carcinomas than currently available immunotherapies. To establish this system we first showed that penetration into...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosslet, K., Steinstraesser, A., Hermentin, P., Kuhlmann, L., Bruynck, A., Magerstaedt, M., Seemann, G., Schwarz, A., Sedlacek, H. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972387/
https://www.ncbi.nlm.nih.gov/pubmed/2039692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972387/
https://www.ncbi.nlm.nih.gov/pubmed/2039692

Ejemplares similares